Le notizie più fresche dal panorama del Venture Capital

Growth Capital supported TrueScreen in closing a seed round

We are thrilled to have supported TrueScreen - Trust as a Service as financial advisor in their closing of a €2.4 million seed round Founded in 2022, TrueScreen is a leading cybersecurity company specializing in the acquisition, signing and management of data with...

Growth Capital supporta Cosmico in un round Serie A da €4 milioni

Growth Capital ha supportato Cosmico in un round Serie A da €4 milioni. Il round è stato guidato da PranaVentures, seguito dai business angel Roberto Marsella e Fabio Troiani, da Intesa Sanpaolo e dal family office 40Jemz Ventures. Cosmico, startup nata nel 2020 per...

Growth Capital and Italian Tech Alliance: VC report Q1-24

Presenting the Q1-24 edition of the Venture Capital Report - Italy, developed by Growth Capital in partnership with Italian Tech Alliance. Key data on Q1-24: ➡️108 Investment rounds with €443 million invested in total ➡️55% of the total capital raised comes from the...

Digital Service Report presented by Growth Capital and Netcomm

The Digital Services in Italian and European Venture Capital": Netcomm's research in collaboration with Growth Capital, analyzing the landscape of investments in innovative startups with a distinctive digital component. The trend of investments in Digital Services in...

Apply for A-Road Batch#5 – Program starts in May 2024

A-Road's acceleration and fundraising program are now accepting applications for Batch#5. We're on the lookout for visionary founders to join us on the path to the Series A round. A-Road stands out as Italy's pioneering acceleration and fundraising program,...

Growth Capital and Italian Tech Alliance: VC Report Q4 & FY-23

Key numbers FY-23:- 325 investment rounds- €1,176M amount invested- 48 Series A, 16 Series B, 44 exits- Sectors: Smart City with most rounds and DeepTech with the largest amount invested- Verticals: FinTech with most rounds and Space Tech with the largest amount...

Growth Capital supports Hyris to sell the company to Ulisse BioMed

Growth Capital supports Hyris Ltd shareholders in their binding agreement to sell 100% of the company to Ulisse BioMed (UBM) for €26.2 million in a reverse takeover deal. Hyris is a hi-tech company active at the intersection of #AI, #medtech and #biotech. Hyris...

Connecting outstanding entrepreneurs  and visionary investors